Update

Placing Orders and Procuring Health Products for 2023

Global Fund Ranks in Good Category in Leading Transparency Index

The Global Fund Joins Partners in Committing to Address Large Shortfalls in Oxygen

A Leap of Pride

Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis

External Quality Assessment: Highest Possible Results for OIG Audit and Investigation Units

New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP

Pandemic Preparedness and Response - Thematic Report

Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department

Conflicts, Crises and Displaced People: How the Global Fund Works in Challenging Operating Environments - Thematic Report

Opportunity for Evaluation of Diagnostic Products

Message from the Executive Director: Global Fund Grants in Liberia